Characteristics of and treatment outcomes in rifampicin-intolerant patients.

Mangat R, Brode SK, Mah HK, Brar MS, Sabur NF

DOI: 10.5588/ijtldopen.23.0466
Published: 2024 Apr
Container: IJTLD open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.5588/ijtldopen.23.0466,
  title = {Characteristics of and treatment outcomes in rifampicin-intolerant patients.},
  author = {Mangat R and Brode SK and Mah HK and Brar MS and Sabur NF},
  year = {2024},
  journal = {IJTLD open},
  doi = {10.5588/ijtldopen.23.0466},
  url = {https://doi.org/10.5588/ijtldopen.23.0466}
}

RIS

TY  - JOUR
TI  - Characteristics of and treatment outcomes in rifampicin-intolerant patients.
AU  - Mangat R
AU  - Brode SK
AU  - Mah HK
AU  - Brar MS
AU  - Sabur NF
PY  - 2024
JO  - IJTLD open
DO  - 10.5588/ijtldopen.23.0466
UR  - https://doi.org/10.5588/ijtldopen.23.0466
ER  -

APA

R, M., SK, B., HK, M., MS, B., & NF, S. (2024). Characteristics of and treatment outcomes in rifampicin-intolerant patients.. IJTLD open. https://doi.org/10.5588/ijtldopen.23.0466

Source records

pubmed · retrieved 2026-09-27T11:21:34.395Z